Clostridioides difficile remains an important public health threat, globally. Since the
emergence of the hypervirulent strain, ribotype 027, new strains have been reported to …

Clostridium difficile ribotype (RT) 017 is an important toxigenic C. difficile RT which, due to a
deletion in the repetitive region of the tcdA gene, only produces functional toxin B. Strains …

Clostridioides difficile causes healthcare-related diarrhoea in high-income countries. Highly
resistant spores persist in healthcare facilities, primarily infecting patients who have recently …

Abstract Introduction The prevalence of Clostridium difficile infection is rapidly increasing
worldwide, but prevalence is difficult to estimate in developing countries where awareness …

Clostridioides difficile infection (CDI) remains a major healthcare problem worldwide,
however, little is known about CDI epidemiology in Iran. Between December 2004 and …

In contrast to the significant resources invested in the diagnosis and prevention of
Clostridium difficile infection (CDI) in resource-rich settings, in resource-limited settings …

Clostridioides difficile infection is an increasing presence worldwide. Prevention is
multipronged, reflecting a complex and evolving epidemiology. Multiple guidelines exist …

Clostridium (Clostridioides) difficile causes toxin-mediated diarrhea and
pseudomembranous colitis, primarily among hospital inpatients. Outbreaks of C. difficile …

Non-toxigenic Clostridioides difficile (NTCD) has been shown to decrease the risk of
recurrent C. difficile infection (CDI) in patients following metronidazole or vancomycin …

Objectives Clostridioides difficile is an important pathogen of healthcare-associated
gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) …